Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Min Zhou, Richu Liang, Quan Liao, Pingfu Deng, Wentao Fan & Chenzhuo Li. (2022) Lumbar Cistern Drainage and Gentamicin Intrathecal Injection in the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Intracranial Infection After Intracerebral Hemorrhage craniotomy: A Case Report. Infection and Drug Resistance 15, pages 6975-6983.
Read now
Read now
Xiuli Chen, Liyuan Yin, Linxiu Peng, Yanshan Liang, Hang Lv & Tonghui Ma. (2020) Synergistic Effect and Mechanism of Plumbagin with Gentamicin Against Carbapenem-Resistant Klebsiella pneumoniae. Infection and Drug Resistance 13, pages 2751-2759.
Read now
Read now
Articles from other publishers (38)
Sara Mahmoud Farhan, Rehab Mahmoud Abd El-Baky, Hala Rady Ahmed, Zeinab Fathalla, Ali Alamri, Hamdy Abdelkader & Adel Al Fatease. (2023) Comparative Investigation into the Roles of Imipenem:Cyclodextrin Complexation and Antibiotic Combination in Combatting Antimicrobial Resistance in Gram-Negative Bacteria. Pharmaceuticals 16:10, pages 1508.
Crossref
Crossref
Saeed Khoshnood, Sousan Akrami, Morteza Saki, Moloudsadat Motahar, Sara Masihzadeh, Sara Daneshfar, Hossein Meghdadi, Effat Abbasi Montazeri, Marjan Abdi & Zahra Farshadzadeh. (2023)
Molecular evaluation of aminoglycosides resistance and biofilm formation in
Klebsiella pneumoniae
clinical isolates: A cross‐sectional study
. Health Science Reports 6:5.
Crossref
Crossref
Inmaculada López Montesinos, Silvia Gómez-Zorrilla, Zaira Raquel Palacios-Baena, Nuria Prim, Daniel Echeverria-Esnal, María Pilar Gracia, María Milagro Montero, Xavier Durán-Jordà, Elena Sendra, Luisa Sorli, Roberto Guerri-Fernandez, Eduardo Padilla, Santiago Grau & Juan Pablo Horcajada. (2021) Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study. Infectious Diseases and Therapy 11:1, pages 335-350.
Crossref
Crossref
Raed Taha Alneama, Aseel Jameel Al-Massody, Bashdar Mahmud Mahmud & Abdolmajid Ghasemian. (2021) The existence and expression of aminoglycoside resistance genes among multidrug-resistant Escherichia coli isolates in intensive care unit centers. Gene Reports 25, pages 101315.
Crossref
Crossref
Diógenes Rodrigues, Giulia Soska Baldissera, Douglas Mathos, Aline Sartori, Alexandre P. Zavascki & Maria Helena Rigatto. (2021) Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity. Brazilian Journal of Microbiology 52:4, pages 1913-1919.
Crossref
Crossref
K. Sermet & S. Alfandari. (2021) Aminoglucósidos. EMC - Tratado de Medicina 25:4, pages 1-4.
Crossref
Crossref
K. Sermet & S. Alfandari. (2021) Aminoglicosidi. EMC - AKOS - Trattato di Medicina 23:4, pages 1-4.
Crossref
Crossref
Pawarisa Terbtothakun, Ozioma Forstinus Nwabor, Thanyaluck Siriyong, Supayang P. Voravuthikunchai & Sarunyou Chusri. (2021) Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring blaNDM-1 and blaNDM-5. Antibiotics 10:8, pages 1023.
Crossref
Crossref
Yanqin Huang, Karol Sokolowski, Amisha Rana, Nidhi Singh, Jiping Wang, Ke Chen, Yinzhi Lang, Jieqiang Zhou, Neera Kadiyala, Fiorella Krapp, Egon A. Ozer, Alan R. Hauser, Jian Li, Jürgen B. Bulitta & Zackery P. Bulman. (2021)
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing
Klebsiella pneumoniae
. Antimicrobial Agents and Chemotherapy 65:9.
Crossref
Crossref
Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, Andrew P Davis & Mariana Castanheira. (2021)
Characterization of
Enterobacter cloacae
and
Citrobacter freundii
species complex isolates with decreased susceptibility to cephalosporins from United States hospitals and activity of ceftazidime/avibactam and comparator agents
. JAC-Antimicrobial Resistance 3:3.
Crossref
Crossref
Parnrada Nulsopapon, Worapong Nasomsong, Manat Pongchaidecha, Dhitiwat Changpradub, Piraporn Juntanawiwat & Wichai Santimaleeworagun. (2021) The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates. Antibiotics 10:6, pages 736.
Crossref
Crossref
Yinzhi Lang, Nirav R. Shah, Xun Tao, Stephanie M. Reeve, Jieqiang Zhou, Bartolome Moya, Alaa R. M. Sayed, Suresh Dharuman, Jeremiah L. Oyer, Alicja J. Copik, Brett A. Fleischer, Eunjeong Shin, Carolin Werkman, Kari B. Basso, Deanna Deveson Lucas, Dhruvitkumar S. Sutaria, Marianne Mégroz, Tae Hwan Kim, Victoria Loudon‐Hossler, Amy Wright, Rossie H. Jimenez‐Nieves, Miranda J. Wallace, Keisha C. Cadet, Yuanyuan Jiao, John D. Boyce, Eric D. LoVullo, Herbert P. Schweizer, Robert A. Bonomo, Nagakumar Bharatham, Brian T. Tsuji, Cornelia B. Landersdorfer, Michael H. Norris, Beom Soo Shin, Arnold Louie, Venkataraman Balasubramanian, Richard E. Lee, George L. Drusano & Jürgen B. Bulitta. (2021) Combating Multidrug‐Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling. Clinical Pharmacology & Therapeutics 109:4, pages 1000-1020.
Crossref
Crossref
Corneliu Ovidiu Vrancianu, Elena Georgiana Dobre, Irina Gheorghe, Ilda Barbu, Roxana Elena Cristian & Mariana Carmen Chifiriuc. (2021) Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections. Microorganisms 9:4, pages 730.
Crossref
Crossref
Junyan Qu, Chunlu Feng, Huan Li & Xiaoju Lv. (2021) Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection. International Journal of Antimicrobial Agents 57:3, pages 106284.
Crossref
Crossref
David A Butler, Amisha P Rana, Fiorella Krapp, Shitalben R Patel, Yanqin Huang, Egon A Ozer, Alan R Hauser & Zackery P Bulman. (2021)
Optimizing aminoglycoside selection for KPC-producing
Klebsiella pneumoniae
with the aminoglycoside-modifying enzyme (AME) gene
aac(6’)-Ib
. Journal of Antimicrobial Chemotherapy 76:3, pages 671-679.
Crossref
Crossref
Marco Fiore, Sveva Di Franco, Aniello Alfieri, Maria Beatrice Passavanti, Maria Caterina Pace, Stephen Petrou, Francesca Martora & Sebastiano Leone. (2020)
Spontaneous bacterial peritonitis due to carbapenemase-producing
Enterobacteriaceae
: Etiology and antibiotic treatment
. World Journal of Hepatology 12:12, pages 1136-1147.
Crossref
Crossref
Zackery P. Bulman, Ryan Cirz, Darin Hildebrandt, Tim Kane, Zuelay Rosario, Ken Wlasichuk, Minjong Park & Logan D. Andrews. (2020) Unraveling the Gentamicin Drug Product Complexity Reveals Variation in Microbiological Activities and Nephrotoxicity. Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Crossref
Felipe Pinheiro VilelaJuliana Pfrimer FalcãoFábio Campioni. (2020)
Analysis of Resistance Gene Prevalence in Whole-Genome Sequenced
Enterobacteriales
from Brazil
. Microbial Drug Resistance 26:6, pages 594-604.
Crossref
Crossref
Elza Ferreira Firmo, Elizabeth Maria Bispo Beltrão, Felipe Rogério Ferreira da Silva, Luis Carlos Alves, Fábio André Brayner, Dyana Leal Veras & Ana Catarina Souza Lopes. (2020) Association of blaNDM-1 with blaKPC-2 and aminoglycoside-modifying enzyme genes among Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens clinical isolates in Brazil. Journal of Global Antimicrobial Resistance 21, pages 255-261.
Crossref
Crossref
Yaoqiang Shi, Chao Li, Guangying Yang, Xueshan Xia, Xiaoqin Mao, Yue Fang, A-Mei Zhang & Yuzhu Song. (2020)
A rapid and accurate method for the detection of four aminoglycoside modifying enzyme drug resistance gene in clinical strains of
Escherichia coli
by a multiplex polymerase chain reaction
. PeerJ 8, pages e8944.
Crossref
Crossref
Tae Hwan Kim, Xun Tao, Bartolome Moya, Yuanyuan Jiao, Kari B. Basso, Jieqiang Zhou, Yinzhi Lang, Dhruvitkumar S. Sutaria, Alexandre P. Zavascki, Afonso L. Barth, Stephanie M. Reeve, Herbert P. Schweizer, Deanna Deveson Lucas, John D. Boyce, Robert A. Bonomo, Richard E. Lee, Beom Soo Shin, Arnold Louie, George L. Drusano & Jürgen B. Bulitta. (2020)
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant
Klebsiella pneumoniae
and
Enterobacter cloacae
. mBio 11:1.
Crossref
Crossref
N. Jung, W.-J. Mayet, P.R. Mertens, J. Meyer (federführend)O.-A. Müller, M. Pfeifer, P. Schellinger, N. Weiss & C.-M. Wendtner. 2020. Rationelle Diagnostik und Therapie in der Inneren Medizin. Rationelle Diagnostik und Therapie in der Inneren Medizin
pL1
pL16.2-10
.
Anna Maria Peri, Yohei Doi, Brian A. Potoski, Patrick N.A. Harris, David L. Paterson & Elda Righi. (2019) Antimicrobial treatment challenges in the era of carbapenem resistance. Diagnostic Microbiology and Infectious Disease 94:4, pages 413-425.
Crossref
Crossref
Yuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, Alexandre P. Zavascki, Hsinyin Tsai, Xun Tao, Dhruvitkumar S. Sutaria, Arnold Louie, John D. Boyce, Deanna Deveson Lucas, Tae Hwan Kim, Brian T. Tsuji, Robert A. Bonomo, George L. Drusano & Jürgen B. Bulitta. (2019) Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials. Antimicrobial Agents and Chemotherapy 63:7.
Crossref
Crossref
Ilias Karaiskos, Styliani Lagou, Konstantinos Pontikis, Vasiliki Rapti & Garyphallia Poulakou. (2019) The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Frontiers in Public Health 7.
Crossref
Crossref
Jürgen B. Bulitta, William W. Hope, Ann E. Eakin, Tina Guina, Vincent H. Tam, Arnold Louie, George L. Drusano & Jennifer L. Hoover. (2019)
Generating Robust and Informative Nonclinical
In Vitro
and
In Vivo
Bacterial Infection Model Efficacy Data To Support Translation to Humans
. Antimicrobial Agents and Chemotherapy 63:5.
Crossref
Crossref
Paola Del Giacomo, Angela Raffaella Losito & Mario Tumbarello. (2019) The role of carbapenem-resistant pathogens in cSSTI and how to manage them. Current Opinion in Infectious Diseases 32:2, pages 113-122.
Crossref
Crossref
Gregory Saraiva Medeiros, Maria Helena Rigatto, Diego Rodrigues Falci & Alexandre P. Zavascki. (2019) Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection. International Journal of Antimicrobial Agents 53:2, pages 152-157.
Crossref
Crossref
Jürgen B. Bulitta, Yuanyuan Jiao, Stefanie K. Drescher, Antonio Oliver, Arnold Louie, Bartolome Moya, Xun Tao, Mathias Wittau, Brian T. Tsuji, Alexandre P. Zavascki, Beom Soo Shin, George L. Drusano, Fritz Sörgel & Cornelia B. Landersdorfer. (2018) Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis. Clinical Pharmacokinetics 58:2, pages 143-156.
Crossref
Crossref
Chau-Chyun Sheu, Ya-Ting Chang, Shang-Yi Lin, Yen-Hsu Chen & Po-Ren Hsueh. (2019) Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options. Frontiers in Microbiology 10.
Crossref
Crossref
Mario Tumbarello, Angela Raffaella Losito & Helen Giamarellou. (2018) Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections. Current Opinion in Infectious Diseases 31:6, pages 566-577.
Crossref
Crossref
Laura C. Antochevis, Cibele M. Magagnin, Aline G. Nunes, Taíse M. Goulart, Amanda S. Martins, Rodrigo Cayô, Ana C. Gales, Afonso L. Barth & Alexandre P. Zavascki. (2018) KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?. Journal of Global Antimicrobial Resistance 15, pages 173-177.
Crossref
Crossref
Brandon Kulengowski, W. Cliff Rutter, Jeffrey J. Campion, Grace C Lee, David J. Feola & David S. Burgess. (2018) Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL- and KPC-producing Enterobacter cloacae. Diagnostic Microbiology and Infectious Disease 92:3, pages 262-266.
Crossref
Crossref
Ann Marie Porreca, Kaede V. Sullivan & Jason C. Gallagher. (2018) The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms. Current Infectious Disease Reports 20:6.
Crossref
Crossref
Ni Wentao, Li Guobao, Zhao Jin, Cui Junchang, Wang Rui, Gao Zhancheng & Liu Youning. (2018) In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. The Journal of Antibiotics 71:5, pages 506-513.
Crossref
Crossref
Jesús Rodríguez-Baño, Belén Gutiérrez-Gutiérrez, Isabel Machuca & Alvaro Pascual. (2018) Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clinical Microbiology Reviews 31:2.
Crossref
Crossref
Zhichang Zhao, Fangjun Lan, Maobai Liu, Weiyuan Chen, Liya Huang, Qili Lin & Bin Li. (2017) Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae. Antimicrobial Resistance & Infection Control 6:1.
Crossref
Crossref
Jae-Hoon KoJin Yang Baek, Kyong Ran Peck, Sun Young Cho, Young Eun Ha, So Hyun Kim, Hee Jae Huh, Nam Yong Lee, Cheol-In Kang, Doo Ryeon Chung & Jae-Hoon Song. (2017) Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene. Journal of Medical Microbiology 66:10, pages 1448-1450.
Crossref
Crossref